ABIOMED (NASDAQ:ABMD) traded on a positive note gaining 0.07 points or 0.07% to be valued at $101.79 per share. Intraday, the shares aggregated $0.06 million in upticks but saw an exodus of $0.37 million in downticks. The net money flow was calculated to be $(-0.31) million with the final up/down ratio coming in at 0.17. The share price has seen a change of 2.58% in value during the week.
The stock has recorded a 20-day Moving Average of 0.52% and the 50-Day Moving Average is 2.6%. The company shares have rallied 50.92% in the past 52 Weeks. On August 13, 2015 The shares registered one year high of $110.68 and one year low was seen on July 8, 2015 at $64.03. The 50-day moving average is $98.95 and the 200 day moving average is recorded at $90.63. S&P 500 has rallied 1.93% during the last 52-weeks.
ABIOMED (NASDAQ:ABMD): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $101.57 and $100.51 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $103.14. The buying momentum continued till the end and the stock did not give up its gains. It closed at $101.76, notching a gain of 0.04% for the day. The total traded volume was 466,838 . The stock had closed at $101.72 on the previous day.
Currently the company Insiders own 10.5% of ABIOMED shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -24.71% . Institutional Investors own 94.24% of ABIOMED shares. During last six month period, the net percent change held by insiders has seen a change of -22.84%. On the companys insider trading activities, The officer (VP Healthcare Solutions), of Abiomed Inc, Greenfield Andrew J had unloaded 9,000 shares at $104.16 per share in a transaction on June 7, 2016. The total value of transaction was $937,440. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Companys products include Impella 2.5, a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD, a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000, a circulatory support system for the temporary support of acute heart failure patients in profound shock, and Symphony, a minimally invasive implantable cardiac assist device.